FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.

FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity. — المؤلف: Wang, Xiaoxin X — Journal of the American Society of Nephrology : JASN 20190715

المؤلف
Wang, Xiaoxin X
النشر
Journal of the American Society of Nephrology : JASN 20190715
الوصف
118-137 p.
الموضوعات
Albuminuria؛ Animals؛ Bile Acids and Salts؛ Chenodeoxycholic Acid؛ Cholesterol؛ Cholic Acids؛ Diabetes Mellitus, Experimental؛ Diabetes Mellitus, Type 2